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Resistance to Theiler’s virus-induced demyelination maps genetically to the MHC class I D region and is associated with
up-regulation of class I products and the presence of MHC-restricted virus-specific cytotoxic CD8/ T cells in the CNS. To
determine the targets of the cytotoxic response, transfected C57SV (Kb, Db) cells expressing LP (including the leader peptide,
VP4, VP2, and VP3 coding sequences), VP4 (including the leader peptide and VP4), VP2, VP3, VP1, or RP (including P2 and
P3) were generated. CNS-infiltrating lymphocytes obtained from virus-infected B10, B10.K (Kk, Dk), B10.RBF (Kb, Df), B10.RFB3
(Kf, Db), and B10.RBQ (Kb, Dq) mice were used as effectors. Specific cytotoxicity to the capsid proteins encoded in the LP
construct, VP2 and VP1, was demonstrated to be H-2Db region restricted and was mediated by CD8/ T cells. No Kb-restricted
virus-specific cytotoxicity response was observed. No specific cytotoxic response against RP-encoded proteins was ob-
served in the CNS of B10 mice. Therefore, both VP1 and VP2 are targets for an H-2D-restricted cytotoxic immune response
against Theiler’s virus infection in the CNS of infected resistant B10 mice. q 1995 Academic Press, Inc.
INTRODUCTION guez et al., 1986). Other investigators also showed a
similar D region influence by analysis of crosses be-
Intracerebral inoculation of mice with Daniel’s (DA) tween SJL and several congeneic recombinant mouse
strain of Theiler’s murine encephalomyelitis virus (TMEV) strains bearing different combinations of MHC genes
results in acute encephalitis with early infection of neu- (Clatch et al., 1985, 1987). Transgenic expression of H-
rons (Dal Canto and Lipton, 1982; Lipton, 1975; Rodriguez 2Db (Azoulay et al., 1994) or H-2Dd (Rodriguez and David,
et al., 1986). Some strains, such as B10 congeneic mice 1995) renders susceptible strains of mice resistant to
expressing H-2b,d,ork haplotypes, clear virus infection from demyelination. Infection of H-2b b2-microglobulin-defi-
CNS, whereas others, such as B10 congeneic mice ex- cient mice which express a low level of MHC class I and
pressing H-2s,q,r,v,f,orp haplotypes, develop viral persis- few CD8/ T cells results in demyelination (Fiette et al.,
tence in the CNS with chronic demyelination. The immu- 1993; Pullen et al., 1993; Rodriguez et al., 1993). This
nopathogenesis of the demyelinating disease in mice indicates that expression of MHC class I products is
of susceptible haplotypes is similar to human multiple important in clearance of TMEV from the CNS of resistant
sclerosis (Dal Canto and Rabinowitz, 1982; Lipton, 1975; mice. The genetic association of disease resistance with
Rodriguez, 1989). Despite evidence for the contribution MHC class I D region molecules strongly suggests that
of background genes (Bureau et al., 1992; Melvold et al., class I-restricted T cells play a primary role in host resis-
1987, 1990; Rodriguez et al., 1992), resistance/suscepti- tance.
bility to TMEV infection maps genetically to the H-2 D Both CD4/ and CD8/ T cells appear to play a role
region (Clatch et al., 1985; Rodriguez et al., 1986). Using in resistance/susceptibility to chronic TMEV infection. In
mouse strains with congeneic recombinant haplotypes, resistant mice, depletion of T cell subsets with mono-
we and others (Clatch et al., 1985; Rodriguez et al., 1986) clonal antibodies (MAbs) directed at CD4/ and CD8/ T
showed that the D region genes were primarily responsi- cells resulted in increased frequency of paralysis and
ble for determining resistance/susceptibility to TMEV-in- death due to acute encephalitis. More extensive CNS
duced demyelination and chronic infection. Deletion of abnormalities were noted by treatment with a hamster
genes within the D region by the use of B10.D2dm1 mice MAb to CD3 or by combined treatment with MAbs to
predisposed previously resistant B10.D2 mice to virus CD4 and CD8 epitopes (Rodriguez et al., 1991). At 7 days
persistence and TMEV-induced demyelination (Rodri- postinfection, CNS-infiltrating lymphocytes isolated from
resistant mice contained a predominance of CD8/ T cells
(Lindsley and Rodriguez, 1989). In contrast, few CD8/ T1 To whom correspondence and reprint requests should be ad-
cells were isolated acutely from the CNS of susceptibledressed at: Mayo Clinic, Department of Immunology, Guggenheim (4),
mice, whereas these cells increased in number through-200 First Street, S.W., Rochester, MN 55905. Fax: (507) 284-1637. E-
mail: RODRIGUEZ@RCF.MAYO.EDU. out chronic infection (Lindsley and Rodriguez, 1989). In
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susceptible mice depletion of CD4/ T cells late in dis- VP2, VP3, VP1, and the proteins encoded by RP construct.
The results showed that DA virus infection of B10 miceease resulted in a modest beneficial effect (Welsh et al.,
1987). We demonstrated that in vivo depletion of CD8/ stimulates the generation of H-2D, but not H-2K, re-
stricted CD8/ T cells against capsid proteins VP2 andT cells in susceptible mice resulted in the diminution in
the number and extent of demyelinating lesions (Rodri- VP1, but not against RP-encoded proteins.
guez and Sriram, 1988), implying that class I-restricted T
cells may also be critical effectors or regulatory cells MATERIALS AND METHODS
during demyelination. However, the role of CD8/ T cells
TMEV and cDNAas effectors for demyelination remains controversial (Bor-
row et al., 1992). The DA virus was originally obtained from J. P. Lehrich
Previous results indicated that intracerebral injection and associates at the University of Chicago (Chicago, IL)
of DA virus evokes both specific and nonspecific cyto- (Lehrich et al., 1976), propagated in BHK-21 cells, and
toxic immune responses in the CNS of resistant B10 mice used in all experiments. The titer of stock DA virus used
(Lindsley et al., 1991). Even though NK cells accounted for infection of fibroblast targets was 2 1 108 PFU/ml.
for some of the cytotoxicity, the majority of the cytotoxicity For infection of mice, TMEV stock was diluted to 2 1 107
in the CNS of infected resistant mice was composed of PFU/ml, and 10 ml of virus (2 1 105 PFU) was injected
H-2-restricted, TMEV-specific CTLs of the CD8/ pheno- into the right cerebral hemisphere. DA virus cDNA
type. Specific cytotoxicity to TMEV mediated by CD8/ T (pDAFL3) was kindly provided by R. P. Roos (Roos et al.,
lymphocytes but H-2Kd-restricted has also been demon- 1989b), University of Chicago (Chicago, IL).
strated in the spleens of infected DBA/2 mice, a suscepti-
ble mouse strain (Rossi et al., 1991). However, it remains Animals
unknown which proteins of DA virus stimulate the gener-
Four- to six-week-old B10 (Kb, Db) mice were pur-ation of virus-specific CTLs and to which H-2 class I
chased from Jackson Laboratories (Bar Harbor, ME).locus cytotoxicity of CNS-infiltrating leukocytes is re-
B10.RFB3 (Kf, Db), B10.RBF (Kb, Df), B10.RBQ (Kb, Dq), andstricted.
B10.K (Kk, Dk) mice were obtained from Mayo Clinic Im-The capsid proteins of TMEV are attractive potential
munogenetic Mouse Colony (C. David, Director).candidates for cytotoxicity. VP1 is the most external viral
capsid protein of TMEV and plays a central role in neu-
Cells
tralization and pathogenesis. The ability of DA virus to
persist and demyelinate is determined in part by a region BHK-21, L (Kk, Dk), and C57SV (Kb, Db) cells were cul-
in the genome that includes VP1. VP1 of DA virus has tured in RPMI 1640 with 5% FCS. The transfected C57SV/
been shown to attenuate the neurovirulence of GDVII LP, C57SV/VP4, C57SV/VP2, C57SV/VP3, C57SV/VP1,
virus and to allow the chimeric virus to persist and demy- and C57SV/RP cells were cultured in RPMI 1640 supple-
elinate (Tangy et al., 1991). Although the role of VP1 as mented with 5% FCS and 300 mg/ml G418.
a determinant of demyelination is disputed (Fu et al.,
Antibodies1990; Rodriguez and Roos, 1992), its importance has
been also suggested by the demonstration of two VP1
MAb Y3 (anti-H-2Kb), MAb B22 (anti-H-2Db), MAbMAb escape variants of DA virus with single amino acid
RL172 (anti-CD4), and MAb 3.168 (anti-CD8) were pro-substitution in VP1 (residue 101 from Thr to Ile and resi-
vided by P. Wettstein (Department of Immunology, Mayodue 268 from Val to Phe, respectively) that are attenuated
Clinic, Rochester, MN). Fluorescein (FITC)-conjugated af-in their ability to persist and cause demyelination (Roos
finipure F(ab* )2 fragment goat anti-mouse IgG was ob-et al., 1989a; Zurbriggen et al., 1991). However, the capsid
tained from Jackson ImmunoResearch Laboratories, Inc.proteins to the left (5* ) coding block of VP1 including
(Bar Harbor, ME). FITC-labeled anti-mouse Lyt-2 andleader peptide, VP4, VP2, and VP3 have also been impli-
streptavidin–phycoerythri (SA–PE)-labeled anti-mousecated in immunopathogenesis. For example, VP2 may be
L3T4 were obtained from Becton–Dickinson (Mountainthe major epitope for CD4/ T cells which play a role in
View, CA).the inflammatory response in SJL/J mice (Gerety et al.,
1994). Construction of expression vectors
The purpose of this study was to evaluate the cytotoxic
lymphocyte response in the CNS against the proteins The LP (nucleotides 1066 to 3003, including leader
peptide, VP4, VP2, and VP3), VP4 (1066 to 1506, includingof Theiler’s virus. Using the H-2Kb gene promoter and
enhancer six recombinant mammalian expression vec- the leader peptide and VP4), VP2 (1507 to 2307), VP3
(2308 to 3003), VP1 (3004 to 3825), and RP (3826 to 7968,tors (designated pKLP, pKVP4, pKVP2, pKVP3, pKVP1,
and pKRP, which cover the entire TMEV genome) were including P2 and P3) cDNA were cloned from plasmid
pDAFL3 (Roos et al., 1989b) and assembled to follow thegenerated to transfect C57SV (H-2b) cells for expression
of the capsid proteins encoded by the LP construct, VP4, first intron of the H-2Kb gene in plasmid 5A (Pullen et al.,
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FIG. 1. Constructs of expression vectors. The pKVP4 (including the leader peptide and VP4), pKVP2, pKVP3, or pKVP1 (A), pKLP (B), and pKRP
plasmids (C) contain three fragments. The first fragment includes the promoter and enhancer sequences (j), the first exon (É), and the first intron
from H-2Kb ( ); the second is the VP4, VP2, VP3, VP1, LP, or RP cDNA cloned from plasmid pDAFL3 (h); the third has the stop codon and 3*
untranslated regions containing the poly(A) signal from H-2Ld (–
  
  –). The ligation site at the intron for VP4, VP2, or VP3 was Sal I–Sal I, but for VP1
was Sal I–XhoI. The constructs were inserted into pUC18 plasmid between XbaI and BamHI sites.
1989). The stop codon TGA and 3* untranslated fragment same as the published DA virus cDNA sequence (Ohara
et al., 1988).containing poly(A) signals cloned from plasmid 5A were
added to the 3* end of LP, VP4, VP2, VP3, VP1, or RP
Transfection of cellscDNA (Figs. 1A–1C). The six constructs (designated
pKLP, pKVP4, pKVP2, pKVP3, pKVP1, and pKRP) con- Six plasmids (pKLP, pKVP4, pKVP2, pKVP3, pKVP1, and
pKRP) were linearized by digestion with XbaI, and plas-tained 299 bp of the 5* noncoding region, including pro-
moter and enhancer-like sequences of H-2Kb (Kimura et mid PRC/CAN containing G418 resistant gene was lin-
earized by digestion with HindIII. The linearized plasmidsal., 1986), the first exon and intron of H-2Kb gene, DA
virus LP, VP4, VP2, VP3, VP1, or RP cDNA, and 659 bp were precipitated by ethanol and then redissolved in
sterile distilled H2O. C57SV cells were cotransfected withof 3* untranslated region of H-2L
d gene including the
stop codon and poly(A) signals (Fig. 1). The expression the linearized pKLP, pKVP4, pKVP2, pKVP3, pKVP1, or
pKRP and PRC/CAN using a calcium phosphate precipi-of the chimeric gene (the first exon of H-2Kb and the LP,
VP4, VP2, VP3, VP1, or RP cDNA) was driven by the H- tation transfection method (Coligan et al., 1987). The cells
were cultured to 80% confluence in a 10-cm dish and fed2Kb promoter and enhancer. The six constructs were then
inserted into pUC18 plasmid, amplified in Escherichia with 10 ml IMDM with 10% FCS 4 hr prior to adding the
DNA. Twenty micrograms of the linearized pKLP, pKVP4,coli (DH5a), purified by PEG precipitation method (Sam-
brook et al., 1989a), and sequenced with the DNA Se- pKVP2, pKVP3, pKVP1, or pKRP DNA plus 3 mg of the
linearized PRC/CAN DNA was mixed in 450 ml of sterilequencing version 2.0 kit (USB, Cleveland, OH) and 35S-
dATP (Amersham Life Science, Arlington Heights, IL). distilled water and successively mixed with 50 ml of 2.5 M
CaCl2 and 500 ml of 21HeBS. The mixture was allowed toDNA sequencing of plasmids pKLP, pKVP4, pKVP2,
pKVP3, pKVP1, and pKRP showed that all the ligation precipitate at room temperature for 20 min and distrib-
uted evenly over the cells. The cells were then culturedsites were correct. VP1 cDNA was the same as the pub-
lished DA virus cDNA sequence (Ohara et al., 1988) ex- overnight, washed with RPMI 1640 three times, and fed
with 10 ml of RPMI 1640 with 5% FCS. Three days latercept for a point mutation (C to G) at site 426 from the
beginning of VP1 cDNA, which did not change the amino the culture medium was changed to RPMI 1640 supple-
mented with 5% FCS and G418 (300 mg/ml). The G418acid sequence. The sequence, however, was identical
to the VP1 cDNA sequence cloned from RNA isolated resistant cells were cloned by means of limiting dilution.
The transfected C57SV cell clones expressing LP, VP4,from DA virus-infected L cells and from the RNA isolated
from the CNS of DA virus-infected mice. Sequencing of VP2, VP3, VP1, or RP were then screened by Northern
blot and reverse transcription (RT)–PCR.LP, VP4, VP2, VP3, and RP cDNA showed that it was the
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Northern blot and RT–PCR RP-transfected C57SV cells, designated C57SV/LP,
C57SV/VP4, C57SV/VP2, C57SV/VP3, C57SV/VP1, or
Isolation of total RNA from the G418 resistant cell C57SV/RP, respectively, was used as a target for the
clones was performed following a single-step method cytotoxicity experiments.
(Chomczynski and Sacchi, 1987). Twenty micrograms of
total RNA isolated from each G418 resistant cell clone
Preparation of CNS-infiltrating lymphocytes (CNS-ILs)
was electrophoresed in 1% formaldehyde–agarose and
from DA virus-infected mice
transferred to a nylon filter as described (Sambrook et
al., 1989b). Northern blotting was performed using [32P]- Mice were inoculated intracerebrally with 2 1 105 PFU
dCTP-labeled LP, VP4, VP2, VP3, VP1, and RP specific of DA virus in 10 ml volume. Seven days postinjection,
cDNA probe. For RT–PCR the first-strand cDNA was syn- the brains and spinal cords were pooled by strain or
thesized by using the First-Strand cDNA synthesis kit treatment group. Mononuclear cells were isolated as de-
(Pharmacia Biotech Inc., Piscataway, NJ). One microliter scribed previously (Lindsley and Rodriguez, 1989).
of reaction mix was used as template for PCR reaction. Briefly, brain and spinal cord were homogenized with a
PCR was carried on for 30 cycles, each consisting of 947 tissue grinder. Twenty milliliters of CNS suspension was
for 1 min, 607 for 2 min, and 727 for 3 min, with primers mixed with 10 ml of Percoll (one part 101 PBS and nine
LP-1 and LP-2 (5* ATGGCTTGCAAACATGGA 3* and 3* parts Percoll, Pharmacia Biotech Inc., Piscataway, NJ)
CAAGAGGAGAGGTGCCATAG 5* ) to verify expression of and centrifuged at 27,000 g for 30 min at 47. The mononu-
LP and VP4 cDNA, primers VP2-1 and VP2-2 (5* GATCAA- clear cell band was removed, washed, precleared of
AACACAGAGGAGAT 3* and 3* TACTCTGACACTATC- erythrocytes with sterile distilled H2O, washed, and
GAGTC 5* ) to verify expression of VP2 cDNA, primers counted. The CNS-ILs were resuspend to 2 1 106/ml in
VP3-1 and VP3-2 (5* AGCCCTATAGCAGTCACAGT 3* and RPMI with 5% FCS, and twofold serial dilutions were
3* GGTGGTTCACCCGCGGGGTC 5* ) to verify expression made to provide effector-to-target ratios of 100:1 to
of VP3 cDNA, primers VP1-1 and VP1-2 (5* GGAAGCGAC- 6.25:1.
AACGCCGAAAA 3* and 3* AGGGGTAAGAGCTTGAACTT
5* ) to verify expression of VP1 cDNA, and primers Preparation of target cells
Kbexon1 and RP1 (5* GACAGGATCCATGGTACCGTG-
L, C57SV, DA virus-infected C57SV, and transfectedCACGCTGCTCCT 3* and 3* CTTAGGGTCCTAAGCCAG
C57SV/LP, C57SV/VP4, C57SV/VP2, C57SV/VP3, C57SV/5* ) to verify expression of RP cDNA. Three G418 resistant
VP1, and C57SV/RP cells served as targets. For infectedclones from pKLP transfection, two from pKVP4 transfec-
targets, C57SV cells or L cells were infected with DAtion, three from pKVP2 transfection, two from pKVP3
virus at 10 PFU/cell 1 day before assay. On the day oftransfection, two from pKVP1 transfection, and three from
assay, target cells were removed from the 25-cm2 flaskspKRP transfection were verified to express LP, VP4, VP2,
by trypsinization, placed into 50-ml tubes, washed twiceVP3, VP1, and RP cDNA both by RT–PCR and by Northern
with RPMI 1640, resuspended in 125 ml of RPMI 1640blot (data not shown). Expression of RP cDNA in
with 65 ml of FCS and 100 ml (500 mCi) of sodium chro-transfected cell clones was also verified by Western blot
mate (51Cr, Amersham Life Science Corp., Arlingtonwith monospecific hamster antibody directed against vi-
Heights, IL), and incubated at 377 for 1 hr. After threerus protein 3C (Ozden et al., 1988). Specific antibodies
washes with RPMI 1640, cells were resuspended to 2 1against VP4 and VP3 are not available to verify that the
104/ml in RPMI 1640 with 5% FCS.expressed RNA is translated.
In vitro depletion of CD4/ or CD8/ T cellsFACS
FACS was used to detect surface H-2 class I antigen CNS-ILs (0.7 1 106) were incubated in 70 ml of 1:5
dilution of MAb 3.168 (anti-CD8) or MAb RL172 (anti-CD4)expression of C57SV, and LP-, VP4-, VP2-, VP3-, VP1-, or
RP-transfected C57SV cells. Cells were incubated in 50 (hybridoma culture supernatants) at 377 for 30 min. Cells
were washed twice with medium without FCS and thenml of primary MAb Y3 specific for H-2Kb and MAb B22
specific for H-2Db (hybridoma culture supernatants, 1:100 incubated in 70 ml of 1:7 dilution of rabbit serum comple-
ment (Pel-Freez Clinical Systems, Brown Deer, WI) at 377dilution) on ice for 30 min and then incubated in 50 ml
of secondary Ab, FITC-conjugated affinipure F(ab* )2 frag- for 30 min. The concentration of mAbs and length of
incubation to obtain complete depletion (more than 95%)ment goat anti-mouse IgG (1:100 dilution), on ice for 30
min. Cells were fixed in 500 ml FACS buffer containing of CD4/ or CD8/ T cells were determined experimentally
and monitored by FACS using FITC-labeled anti-mouse1% formaldehyde at RT for 30 min or at 47 overnight
and analyzed with a FACscan (Becton–Dickinson). The Lyt2 and SA–PE-labeled anti-mouse L3T4 reagents. The
cells were washed twice and resuspended in 0.7 ml ofresults showed that these cells expressed H-2 class I Kb
and Db antigens on the cell surface (data not shown). RPMI with 5% FCS. One hundred microliters of cell sus-
pension was added to suitable wells in a 96-well round-One line from each of the LP-, VP4-, VP2-, VP3-, VP1-, or
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bottom plate. Control wells received 100 ml of nontreated ates the specific cytotoxic response, transfected C57SV/
VP4, C57SV/VP2, and C57SV/VP3 expressing VP4 (includ-CNS-ILs (1 1 106/ml).
ing the leader peptide and VP4), VP2, or VP3, respec-
tively, were generated as targets for cytotoxicity experi-Cytotoxicity assay
ment. CNS-ILs isolated from B10 infected with DA virus
The target cell suspensions (100 ml) were placed in were used as effectors. Transfected C57SV/LP was used
96-well round-bottom microtiter plates (Nunc, Denmark). as positive control. The CNS-ILs isolated from DA-in-
The effector cell suspensions (100 ml) were added in fected B10 mice lysed transfected C57SV/LP and C57SV/
triplicate to the targets, resulting in final effector-to-target VP2, but not C57SV/VP4 and C57SV/VP3 (Fig. 3). These
ratios of 100, 50, 25, 12.5, and 6.25 to 1. Wells of targets results indicated that VP2 was the responsible protein
also received medium alone or 10% Triton X-100 (Sigma in LP that generated the specific cytotoxic response.
Chemical, St. Louis, MO) in triplicate to determine spon-
taneous release and maximum release of chromium from T cells responsible for anti-capsid protein cytotoxicity
targets. Plates were incubated for 5 hr at 377 in 5% CO2 . were of the CD8/ phenotype
Supernatants were harvested with a Skatron Supernatant
To determine the T cell subsets responsible for cyto-collection system (Skatron Instruments, Inc., Sterling, VA)
toxicity, MAb RL172 (anti-CD4) and MAb 3.168 (anti-CD8)and assayed in a gamma counter (Beckman Gamma
were used in vitro with rabbit serum complement to de-5500, Beckman Instruments, Irvine, CA). Mean radioactiv-
plete CD4/ or CD8/ T cells from CNS-ILs isolated fromity values were calculated from triplicate wells, and re-
DA virus-infected B10 mice prior to addition of 51Cr-la-sults were expressed as percentage specific lysis ac-
beled targets (effector to target ratio of 50:1). Anti-VP1cording to the formula [(experimental counts0 spontane-
cytotoxicity in CNS-ILs from B10 mice was inhibited com-ous counts)/(maximum counts 0 spontaneous counts)]
pletely by depletion of CD8/ T cells (0%, P  0.01 com-1 100%. The standard error of the mean was determined
pared to virus-specific cytotoxicity of nontreated CNS-from the results obtained from pooled lymphocyte sam-
ILs; 36%), whereas no effect was seen by depletion ofples in triplicate wells. Statistical comparisons were per-
CD4/ T cells (31.8%, P 0.05 compared to virus-specificformed by the unpaired Student’s t test.
cytotoxicity of nontreated CNS-ILs) (Fig. 4).
RESULTS Cytotoxicity against VP1- and LP-encoded capsid
proteins in the CNS-ILs of infected resistant miceDemonstration of cytotoxicity against LP-encoded
was H-2 restrictedproteins, VP1, and VP2 in CNS-ILs from infected B10
mice CNS-ILs isolated from another resistant mouse strain
[B10.K (Kk, Dk)] infected for 7 days were used as effectorsCNS-ILs from 7-day-infected B10 (Kb, Db) mice were
against C57SV cells (Kb, Db), DA virus-infected C57SVused as effectors in the cytotoxicity experiments. C57SV
cells, transfected C57SV/VP1 cells, transfected C57SV/(Kb, Db), DA virus-infected C57SV, transfected C57SV/
LP cells, uninfected L cells (Kk, Dk), and DA virus-infectedVP1, and C57SV/LP cells were used as targets. CNS-ILs
L cells as targets (effector to target ratio of 50:1). CNS-lysed DA virus-infected C57SV, transfected C57SV/VP1
ILs isolated from B10.K mice showed killing of DA virus-(Fig. 2A), and C57SV/LP cells (Fig. 2B), but did not lyse
infected H-2 matched L cells (34.5%), but did not killnoninfected C57SV cells (Figs. 2A and 2B). A statistically
noninfected L cells (0%), H-2 mismatched noninfectedsignificant difference in the percentage specific cytotox-
C57SV cells (1.3%), DA virus-infected C57SV cells (0%),icity was observed between noninfected C57SV cells ver-
transfected C57SV/VP1 cells (0%), or C57SV/LP cells (0%).sus DA virus-infected C57SV cells, transfected C57SV/
CNS-ILs from H-2b mice lysed DA-infected H-2b express-VP1, or C57SV/LP cells (effector to target ratio at 100:1,
ing C57SV cells (22%) but not infected H-2k-expressingP 0.01). However, no cytotoxicity was detected against
L cells (4%). These findings are consistent with our previ-RP-transfected C57SV cells in the CNS of DA virus-in-
ous conclusion (Lindsley et al., 1991) that cytotoxicityfected B10 mice (data not shown), although these cells
against TMEV by CNS-ILs of infected mice is H-2 re-were verified to express mRNA and the proteins encoded
stricted.by pKRP construct by RT–PCR and Western blot and
were shown to express class I products by FACS. The
The cytotoxic immune response to LP-encoded
extent of cytotoxic activity in CNS-ILs from uninfected
proteins, VP1, and VP2 was restricted exclusively to
mice could not be determined because very few or no
the H-2D locus
lymphocytes were present in the CNS of uninfected mice.
No cytotoxic activity was observed against infected and CNS-ILs isolated from three congeneic strains of mice,
B10.RBF (Kb, Df), B10.RBQ (Kb, Dq), and B10.RFB3 (Kf, Db),transfected targets in the spleen cells from noninfected
B10 mice (data not shown). infected with DA virus, were used as effectors against unin-
fected C57SV (Kb, Db), DA virus-infected C57SV, transfectedTo further determine which capsid protein in LP gener-
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FIG. 2. Cytotoxicity to VP1 (A) and LP (B) in CNS-ILs from B10 mice 7 days following infection. Cytotoxicity to VP1 and LP were assayed against
VP1- or LP-transfected C57SV cells. DA virus-infected C57SV cells were used as positive controls and noninfected C57SV cells as negative controls.
The results represent the pooled activity of CNS-ILs isolated from 10 B10 mice. Lysis against DA virus-infected C57SV, C57SV/VP1, and C57SV/LP
by CNS-ILs was significantly greater than against noninfected C57SV cells (P  0.01, effector to target ratio at 100:1).
C57SV/VP1, transfected C57SV/LP, transfected C57SV/VP4, C57SV/LP (Fig. 5B), transfected C57SV/VP4 (Fig. 6), and
transfected C57SV/VP3 (Fig. 6). These results indicated thattransfected C57SV/VP2, and transfected C57SV/VP3 cells
as targets. CNS-ILs isolated from B10.RFB3 mice lysed DA the cytotoxic activity against VP1, LP-encoded capsid pro-
teins, VP2, and DA virus in the CNS of infected recombinantvirus-infected C57SV, transfected C57SV/VP1 (Fig. 5A),
transfected C57SV/LP cells (Fig. 5B), and transfected mice with B10 background during early infection was H-2
Db but not H-2 Kb restricted.C57SV/VP2 (Fig. 6), but did not lyse uninfected C57SV cells
(Figs. 5 and 6), transfected C57SV/VP4 (Fig. 6), and
transfected C57SV/VP3 (Fig. 6). The CNS-ILs isolated from
B10.RBF and B10.RBQ mice did not lyse uninfected C57SV
cells, DA-infected C57SV, transfected C57SV/VP1 (Fig. 5A),
FIG. 4. Effect of CD4/ or CD8/ T cell depletion on anti-VP1 cytotoxic-
ity in CNS-ILs from DA virus-infected B10 mice. Cytotoxicity to VP1 was
assayed with untreated cells and following depletion of CD4/ T cells
or CD8/ T cells. Results represent the pooled activity of CNS-ILs iso-FIG. 3. Demonstration that VP2 is the protein responsible for generat-
ing the cytotoxic response in the LP construct. Seven days postinfection lated from 10 infected B10 mice. Effector to target ratio was 50:1 before
treatment. Depletion of CD4/ T cells did not influence the cytotoxicityCNS-ILs isolated from B10 served as effectors. The effector to target
ratio was 100:1. Results represent pooled cytotoxic activity in CNS- to VP1 (P  0.05). However, depletion of CD8/ T cells completely
inhibited the lysis of C57SV/VP1 cells by CNS-ILs (P  0.01 comparedILs from 10 infected mice. CNS-ILs isolated from B10 (Kb, Db) lysed
transfected C57SV/LP and C57SV/VP2 cells, but did not lyse uninfected to that of nontreatment group, and P  0.05 compared to those of
noninfected C57SV cells).C57SV, C57SV/VP4, and C57SV/VP3.
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FIG. 5. Demonstration of cytotoxicity to VP1 and capsid proteins encoded by LP in CNS-ILs from B10.RFB3 (Kf, Db), B10.RBF (Kb, Df), and B10.RBQ
(Kb, Dq) mice 7 days postinfection by using uninfected C57SV (Kb, Db), DA virus-infected C57SV, and transfected C57SV/VP1 (A) and transfected
C57SV/LP (B) cells. The effector to target ratio was 100:1. The results represent the pooled cytotoxic activity in CNS-ILs from 10 infected mice of
each strain. CNS-ILs from B10.RFB3 mice lysed DA virus-infected C57SV, transfected C57SV/VP1, and transfected C57SV/LP cells, but not noninfected
C57SV cells (P  0.01), whereas the CNS-ILs from B10.RBF and B10.RBQ mice did not lyse C57SV, C57SV/VP1, C57SV/LP, and DA virus-infected
C57SV cells (P  0.05).
DISCUSSION established that only H-2D, but not H-2K, is responsible
for genetically determining resistance to virus-induced
Previous experiments had indicated that TMEV infec-
demyelination. To evaluate the proteins involved in cyto-
tion could stimulate virus-specific cytotoxicity in the CNS
toxicity, we used an H-2Kb promoter and enhancer to
(Lindsley et al., 1991), but the proteins responsible for
express six chimeric proteins, including the first exon of
evoking this response were unknown. In addition, it was
the H-2Kb gene along with the LP-encoded proteins
(leader peptide, VP4, VP2, and VP3) mapping to the left
of VP1 in the TMEV genome, VP4 (including the leader
peptide and VP4), VP2, VP3, VP1, or RP-encoded proteins
(P2 and P3) mapping to the right of VP1 in the TMEV
genome. The constructed plasmids, pKLP, pKVP4,
pKVP2, pKVP3, pKVP1, and pKRP, covering the entire
TMEV genome, were used to generate transfected
C57SV cell clones which served as targets for the cyto-
toxicity experiments. We showed that both VP1 and VP2
serve as targets for T-cell-mediated cytotoxicity in CNS-
ILs isolated from B10 mice which are resistant to chronic
infection and demyelination. Depletion of NK cells in vivo
did not inhibit cytotoxicity against VP1- and LP-encoded
capsid proteins (data not shown). No cytotoxicity against
the proteins encoded by RP construct was detected. We
also demonstrated that cytotoxicity to VP1 or VP2 is re-
stricted exclusively to the H-2Db locus.
FIG. 6. Demonstration of cytotoxicity to VP4, VP2, and VP3 in the For cytotoxicity to function in the CNS, it is necessaryCNS of B10.RFB3 (Kf, Db), B10.RBF (Kb, Df), and B10.RBQ (Kb, Dq) mice.
that viral peptides combine with proteins derived from aSeven days postinfection CNS-ILs were isolated from B10.RFB3,
class I MHC gene. Although CNS cells do not normallyB10.RBF, and B10.RBQ mice and served as effectors. The effector to
target ratio was 100:1. Results represent pooled cytotoxic activity in express MHC antigens (Wong et al., 1984), endothelial
CNS-ILs from 10 infected mice. CNS-ILs isolated from B10.RFB3 mice cells, astrocytes, and microglia express class I and class
lysed C57SV/VP2 cells, but did not lyse uninfected C57SV, C57SV/
II molecules following TMEV infection (Altintas et al.,VP4 (including the leader peptide and VP4), and C57SV/VP3. CNS-ILs
1993; Rodriguez et al., 1987). However, the ability of neu-isolated from B10.RBF and B10.RBQ mice did not lyse all of the unin-
fected C57SV, C57SV/VP4, C57SV/VP2, and C57SV/VP3 (P  0.05). rons to express MHC antigens remains uncertain. Intra-
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cerebral inoculation of TMEV ‘‘up-regulates’’ both H-2K sistance/susceptibility to H-2D with the demonstration of
H-2Db-restricted CTL responses to capsid proteins VP1and H-2D antigen expression in the brain and spinal cord
of resistant B10 mice, which returns to baseline by 90 and VP2 but not to RP-encoded proteins. It appears that
multiple peptides (at least one in VP1 and one in VP2)days (Altintas et al., 1993). However, infection of suscepti-
ble mice results in a greater increase in H-2D relative to are restricted to H-2Db, but not H-2Kb. The detection of
a CD8/ T-cell-mediated and H-2Db-restricted immune re-H-2K antigen expression in the CNS at all postinfection
observation periods (Altintas et al., 1993). This suggests sponse to DA infectious virus, VP1 and VP2, suggests
that this immune response may play the crucial role inthat unknown antigens are presented by MHC-express-
ing nervous system cells to circulating T cells which are clearing virus from the CNS of B10 mice during early
infection. Cytotoxic T lymphocyte lines against VP2 andactivated and either lyse antigen-positive CNS cells or
secrete soluble mediators of inflammation. In the present VP1 are being generated in our laboratory and sequenc-
ing of DA virus peptides presented by class I moleculesexperiments we demonstrated that the antigenic determi-
nants derived from the structural genes encoding VP1 to CD8/ T cells is in progress. These experiments may
be critical for understanding why certain strains of miceand VP2 capsid proteins are important targets of the
specific cytotoxic immune response in the CNS of in- are resistant to TMEV-induced demyelination and others
are not.fected resistant B10 mice. The cytotoxic effector re-
sponse was mediated predominantly by CD8/ T cells
because in vitro depletion of CD8/ T cells but not CD4/ ACKNOWLEDGMENTS
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